Kyowa Hakko Kirin To Launch First Antibody Drug With Companion Diagnostic In 2011
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin is getting its first antibody KW-0761 ready to commercialize in the U.S. The Tokyo-based Japanese antibody drug maker aims for a 2011 NDA submission and 2012 market launch